AbCellera Biologics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $11.6M | — |
| FY2019 | — | $10.3M | — |
| FY2020 | — | $830.5M | $594.1M |
| FY2021 | — | $1.03B | $476.1M |
| FY2022 | — | $1.23B | $386.5M |
| FY2023 | — | $1.15B | $133.3M |
| FY2024 | — | $1.06B | $156.3M |
| FY2025 | — | $966.9M | $128.5M |